StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

Eisen(II)oxalat

Ferrous Oxalate

HCID 10589
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
516-03-0
Standard-SMILES
O=C([O-])C(=O)[O-].[Fe+2]
InChIKey
OWZIYWAUNZMLRT-UHFFFAOYSA-L
Summenformel
C2FeO4
Durchschnittliche Molmasse
143,86 g/mol
Monoisotopische Masse
143,914594

Überblick

Ferrous oxalate is an odorless yellow solid. Insoluble in water and denser in water. Sinks in water. (USCG, 1999)

Namen und Bezeichner

Bevorzugter Name
Ferrous Oxalate
IUPAC
iron(2+);oxalate
Lokaler Name
Eisen(II)oxalat
Englischer Name
Ferrous oxalate
Summenformel
C2FeO4
Molmasse
143.86

Namen und Synonyme

FERROUS OXALATE516-03-0Iron(II) oxalateIron protoxalateIron(2+) oxalateDZP4YV3ICVUNII-DZP4YV3ICVIron oxalate (FeC2O4)EINECS 208-217-4Oxalic acid, iron(2+) salt (1:1)HSDB 463FERROUS OXALATE [MI]
Weitere Namen anzeigen
IRON OXALATEferrox[qr]Fe2C2O4.2H2Oironoxalate[qr]IRON (II) OXALATEironprotoxalate[qr]iron(ii)oxalate[qr]iron(2+)oxalate[qr]Iron(Ii)Oxalate,Gpr
Ethanedioic acid, iron(2+) salt (1:1)FERROUS OXALATE [HSDB]FERROX (FE(C2O4))FERROUS OXALATE [MART.]FERROUS OXALATE (1:1)FERROUS OXALATE [WHO-DD]Iron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]-FERROUS OXALATE (FE(C2O4))

Datenbank-Bezeichner

CAS
516-03-0、6047-25-2
PubChem CID
10589
DTXSID
DTXSID4060159
UNII
DZP4YV3ICV

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
80,3 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
0
Schwere Atome
7
Formalladung
0
Komplexität
60,5

Experimentelle und physikochemische Eigenschaften

Chemical ClassesMetals -> Metals, Inorganic Compounds
Density · 2 Einträge

2.3 at 68 °F (USCG, 1999) - Denser than water; will sink

Pale yellow crystaline powder. Odorless; decomp AT 150-160 °C on heating in air. Density: 2.28. Slightly soluble in water; soluble in dilute mineral acids. /Dihydrate/

Melting PointMP: DECOMP 190 °C /DIHYDRATE/
Physical Description · 2 Einträge

Ferrous oxalate is an odorless yellow solid. Insoluble in water and denser in water. Sinks in water. (USCG, 1999)

Dihydrate: Pale yellow odorless solid, slightly soluble in water; [Merck Index] Pale yellow odorless crystalline powder; [MSDSonline]

Other Experimental Properties · 3 Einträge

RHOMBIC /DIHYDRATE/

Yellow crystals /Ferrous oxalate dihydrate/

Sugar, glycerin, & many organic hydroxy acids hinder precipitation. In neutral solution, soluble carbonates, phosphates, & oxalates produce precipitation. /Ferrous salts/

Physikochemische Eigenschaften

Schmelzpunkt

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

Warning

H302+H312 (45.1%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oral; acute toxicity, dermal]

P264, P270, P280, P301+P317, P302+P352, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 82 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H302+H312 (39%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oral; acute toxicity, dermal]

Gefahrenhinweise

Regulatory Information · 4 Einträge

Chemical: Ethanedioic acid, iron(2+) salt (1:1)

Chemical: Iron, diaqua(ethanedioato(2-)-O,O')-

REACH registered substance: Iron(II) oxalate (EC: 208-217-4)

Iron (II) oxalate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety Information · 2 Einträge

Evaluation - Chemicals that are unlikely to require further regulation to manage risks to human health

Evaluation - Chemicals not considered for in depth evaluation - Not commercially active in Australia

Fire HazardsSpecial Hazards of Combustion Products: Iron fume or iron oxide fume may form in fire. (USCG, 1999)
Health Hazards · 1 Eintrag

Inhalation of dust may cause irritation of nose and throat. Ingestion causes burning pain in throat and stomach; mucous membranes turn white; can also cause vomiting, weak pulse, collapse, and death. Dust irritates eyes and may irritate skin on prolonged contact. (USCG, 1999)

Chemie und Industrie

Pharmakologische Informationen

Absorption, Distribution and Excretion · 2 Einträge

...Bioavailability of Ferosol-1 /(a ferrous oxalate antianemic powder including copper, zinc, and cobalt) was determined/ by giving it to rabbits with experimental posthemorrhagic anemia. ...Iron from Ferosol-1 was found to be well assimilated and to take place in hemopoetic processes of rabbit. /Ferosol-1/

In hemochromatosis and other disorders associated with iron overload, a significant fraction of the total iron in plasma circulates in the form of low molecular weight complexes not bound to transferrin. Efficient and unregulated clearance of this form of iron by the liver may account for the hepatic iron loading and toxicity that characterize these diseases. ...This possibility /was tested/ by examining the hepatic removal process for representative iron complexes in the single-pass perfused rat liver. Hepatic uptake of both ferrous and ferric 55Fe from ultrafiltered human serum was found to be highly efficient and effectively irreversible (single-pass extraction of 1 microM iron, 58-75%). Similar high efficiencies were seen for iron complexed to specific physiologic and nonphysiologic coordinators, including histidine, citrate, fructose, oxalate and glutamate, and tricine. Because of lower plasma flow rates, single-pass extraction of these iron complexes in vivo should be even greater. Autoradiography confirmed that most iron had been removed by parenchymal cells. Hepatic removal from Krebs-tricine buffer was saturable with similar kinetic parameters for ferrous and ferric iron (apparent Km, 14-22 microM; V max, 24-38 nmol/min/g liver). These findings suggest that high levels of non-transferrin-bound iron in plasma may be an important cause of hepatic iron loading in iron overload states.

Verwendung und Herstellung

Uses · 5 Einträge

Used as a photographic developer (silver bromide-gelatin plates), glass tint (sunglasses and windshields), decorative glass colorant, and pigment (plastics, paints, and lacquers); [Merck Index]

Painting (Pigments, Binders, and Biocides) [Category: Paint]

Glassblowing [Category: Hobbies]

Photographic developer for silver bromide-gelatin plates; for decorative glassware; to impart a greenish-brown tint to optical glass (sunglasses, windshields, railroad car windows); pigment for plastics, paints, lacquers.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EC Number
208-217-4、611-981-5
Nikkaji
J415D
190 °C · 190°C
Dichte
2.3 · 2.30
Dampfdruck
0.038 Pa · 0.038Pa at 25℃
storage temp.
Inert atmosphere,Room Temperature
Löslichkeit
Soluble in acids
Aggregatzustand
Powder
Wasserlöslichkeit
Slightly soluble
InChI
InChI=1S/C2H2O4.Fe/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+2/p-2
InChIKey
OWZIYWAUNZMLRT-UHFFFAOYSA-L
SMILES
O=C1O[Fe]OC1=O
LogP
-0.855 · -0.855
CAS Datenbank
516 · 516-03-0(CAS DataBase Reference)
EPA chemische Informationen
2 · Iron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]- (516-03-0)
Hazards Summary
An eye, nose, and throat irritant; [CAMEO] An irritant; [MSDSonline] See Iron salts, soluble.
Reactive GroupSalts, Basic
Reactivity ProfileWeak inorganic reducing agents, such as FERROUS OXALATE, react with oxidizing agents to generate heat and products that may be flammable, combustible, or otherwise reactive.
Air and Water ReactionsInsoluble in water.
Hazard Classes and Categories · 2 Einträge

Acute Tox. 4 (100%)

Acute Tox. 4 (100%)

Federal Drinking Water GuidelinesEPA 300 ug/L /Iron/
Skin, Eye, and Respiratory IrritationsIf inhaled, iron is a local irritant to the lung and gastrointestinal tract. /Iron compounds/
Hazardous Reactivities and IncompatibilitiesEvolves carbon monoxide on heating

Sicherheit und Schutzausrüstung

First Aid(must be prompt)
Disposal Methods · 1 Eintrag

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Preventive Measures · 3 Einträge

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants.

SRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.

All ... /iron/ preparations should be kept in child-proof bottles. /Iron preparations/

Threshold Limit Values (TLV)1.0 [mg/m3], as Fe (soluble iron salts)
Protective Action Criteria (PAC) · 3 Einträge

5.2 [mg/m3]

57 [mg/m3]

340 [mg/m3]

Personal Protective Equipment (PPE)Dust mask; goggles or face shield; protective gloves (USCG, 1999)
Other Standards Regulations and GuidelinesAustralia, Belgium, Finland, Italy, Netherlands, & Switzerland: 1 mg/cu m. /Iron salts/

Toxikologische Informationen

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Non-Human Toxicity Excerpts · 2 Einträge

/LABORATORY ANIMALS: Acute Exposure/ /Investigators/ ...synthesized ferrous oxalate and prepared a stable antianemic powder Ferosol-1 including copper, zinc and cobalt. ...To estimate a local action of this powder... guinea pigs... were /used/. ...Ferosol-1 is of low toxicity (LD50 = 2.25 g/kg), it does not irritate mucosa of duodenum and ventriculus and could be used orally. ... /Ferosol-1/

/LABORATORY ANIMALS: Acute Exposure/ Experiments with white mice showed low toxicity of Ferosol-2 (LD50 = 4.3 g/kg, for 1 composition and 4.6 g/kg for 2 composition). It does not irritate mucosa of duodenum and ventriculus. /Ferosol-2/

Populations at Special Risk · 1 Eintrag

...There is concern that the individual with metabolic defects that impair the ability to regulate iron absorption will be at risk from excessive exposure to iron, primarily as a result of acceleration of accumulation of iron in the body and an earlier onset of clinical symptoms of the disease. /Iron salts/

Antidote and Emergency Treatment · 5 Einträge

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations as needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover chemical bums with dry, sterile dressings after decontamination ... . /Oxalate and Related Compounds/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the unconscious patient. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with lactated Ringer's /SRP: "To keep open", minimal flow rate/. Watch for signs of fluid overload. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Oxalate and Related Compounds/

Maintain an open airway and assist ventilation if necessary. Treat shock caused by hemorrhagic gastrointestinitis aggressively with intravenous crystalloid fluids, and replace blood if needed. Patients are often markedly hypovolemic owing to gastrointestinal losses and third spacing of fluids into the intestinal wall and interstitial space. Treat coma, seizures, and metabolic acidosis if they occur. For seriously intoxicated victims (eg, shock, severe acidosis, and/or serum iron > 500-600 mcg/dL) administer deferoxamine. Monitor the urine for the urine for the characteristic orange or pink deferoxamine-iron complex. Therapy may be stopped when the urine returns to normal or when the serum iron level decreases to the normal range. Prolonged deferoxamine has been associated with adult respiratory distress syndrome and Yersinia sepsis.

Activated charcoal is not effective. Ipecac is not recommended, because it can aggravate iron-induced gastrointestinal irritation and interfere with whole bowel irrigation. Consider gastric lavage if product was a liquid formulation or tablets were chewed. Do-not use phosphate-containing solutions for lavage; these may result in life-threatening hypernatremia, hyperphosphatemia, and hypocalcemia. Bicarbonate and deferoxamine lavage are of doubtful efficacy. Deferoxamine lavage is not effective and may enhance iron absorption. Whole-bowel irrigation is very effective for ingested tablets and may be considered first-line treatment, especially if large numbers of tablets are visible on plain abdominal x-ray. Massive ingestions may lead to concretions or bezoars. Repeated or prolonged whole-bowel irrigation may remove tablets. Endoscopy or surgical gastrotomy is rarely required.

Hemodialysis and hemoperfusion are not effective for removing iron but may be necessary to remove iron-deferoxamine complex in patients with renal failure. Exchange transfusion is occasionally used for massive pediatric ingestions but is of questionable efficacy.

Regulatorische Informationen

Federal Drinking Water GuidelinesEPA 300 ug/L /Iron/

Sicherheitsdaten

tsca
TSCA listed
ridadr
UN3288
hazard_class
6.1
packing_group
III
Giftige Stoffe Daten
516-03-0(Hazardous Substances Data)

Catalysts, pigments, drugs, agriculture, nutrition, metallurgy, and leather tanning. /Iron compounds/

Methods of ManufacturingBy the interaction of solutions ferrous sulfate and sodium oxalate.
Formulations/PreparationsFerosol-1: Antianemic powder including copper, zinc, and cobalt. Ferosol-2: antianemic powder including copper, zinc, cobalt, manganese, and calcium (sometimes ascorbic acid also).
General Manufacturing InformationIron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]-: ACTIVE
Anwendungen · 2 Einträge

BeschreibungFerrous oxalate, or iron (II) oxalate, is a chemical compound consisting of one iron (II) ion (Fe2+) and one oxalate ion (C2O42-). It has the chemical formula FeC2O4. Iron(II) oxalate is more commonly encountered as the dihydrate, FeC2O4·2H2O . Its crystal structure consists of chains of oxalatebridged iron atoms, capped by water molecules. When heated, it dehydrates and decomposes into carbon dioxide, carbon monoxide, iron oxides and pyrophoric black iron.

VerwendenPhotographic developer, pigment in glass, plastics, paints.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

WasserKohlenstoffdioxid

Nachgelagerte Produkte

Ferrous oxalate dihydrate

Anbieter100 Anbieter

山东旭晨化工科技有限公司0533-15715337262 15715337262 · [email protected]
南通润丰石油化工有限公司66017690 19952660367 · [email protected]
天津市光复科技发展有限公司022-85689490 13132141716 · [email protected]
毕佳索(上海毕得医药科技股份有限公司)400-6005915 · [email protected]
湖北成丰化工有限公司13125175253 · [email protected]
武汉欣扬瑞和化学科技有限公司13720274133 · [email protected]
四川华南无机盐有限公司15223036127 · [email protected]
山东海舟生物工程有限公司130-0567-0367 13006570367 · [email protected]
上海腾准生物科技有限公司19821570922 · [email protected]
武汉零加一化工有限公司15972036926 15972036926 · [email protected]
河北展药生物科技有限公司15369953316 +8615369953316 · [email protected]
武汉吉业升化工有限公司027-83360216 18040558719 · [email protected]
陕西缔都化学有限公司029-029-81123119 17391733320 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
Hebei Yanxi Chemical Co., Ltd.+86-17531190177 · [email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
武汉吉业升化工有限公司15387013945 · [email protected]
江苏普乐司生物科技有限公司0513-66017706 18551496367 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
武汉市聚舜化工有限公司027-02783261126 18971318572 · [email protected]
安耐吉化学&3A(安徽泽升科技有限公司)021-58432009 400-005-6266 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
武汉卡诺斯科技有限公司027-83238443 15327105076 · [email protected]
湖北兴琰新材料科技有限公司13129948835 · [email protected]
湖北长耀生物科技有限公司17683887209 17683887209 · [email protected]
武汉吉业升化工有限公司13545274181 15307147230 · [email protected]
上海泰坦科技股份有限公司4006009262 13023226327 · [email protected]
武汉贝乐叶生物医药科技有限公司18086118076; 18086118070 · [email protected]
孝感深远化工有限公司15527621225; 15527621225 · [email protected]
上海悦耳化学品有限公司+86-021-50890968,021-50891159 +86-18601776121 · [email protected]
四川库利南科技有限公司400-1166-196 18981987031 · [email protected]
武汉吉业升化工有限公司027-13545242311 13545242311 · [email protected]
艾科试剂4008-755-333 18080918076 · [email protected]
武汉吉业升化工有限公司15927657268 · [email protected]
北京环宇世纪化学科技有限公司hysj_bj.com
上海湄水化工科技有限公司021-60549325 18616193163
HBCChem, Inc.+1-510-219-6317 · [email protected]
成都零六生物科技有限公司400-1166-196 13458535857 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海麦克林生化科技股份有限公司15221275939 15221275939 · [email protected]
康迪斯化工(湖北)有限公司13125172151 · [email protected]
上海兴鲁化工科技有限公司02120970332 · [email protected]
武汉贝乐叶生物医药科技有限公司18086118078 · [email protected]
湖北巨胜科技有限公司027-59599241 18871490274 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
广东翁江化学试剂有限公司0751-2815987 13927875076 · [email protected]
湖北军瑞生物科技有限公司13971166412 · [email protected]